Skip to main content

Crisel to Distribute Cellix Products

NEW YORK (GenomeWeb News) – Cellix today said that Crisel Instruments will distribute the firm's microfluidic products throughout Italy.

Crisel will now offer in Italy Cellix's microfluidic pump, the Mirus Nanopump, and Vena8 biochips for cell adhesion and migration under conditions of physiological flow, the firm said.

"Crisel was selected for the Italian market due to their extensive knowledge in [the] syringe pump market coupled with their background in cellular biology — they have the right customer base for Cellix's products," Cellix CEO Vivienne Williams said in a statement.

Further terms of the pact were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.